Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients

Journal of Infectious Diseases

Volumn 181, Issue 5, 2000, Pages 1607-1613

  Moja, Philippe ^a   Tranchat, Corinne ^b   Tchou, Isabelle ^a   Pozzetto, Bruno ^a   Lucht, Frédéric ^a   Desgranges, Claude ^b   Genin, Christian ^a,c  

^a UNIVERSITÉ JEAN MONNET   (France)

^b Inst Natl de la Sante et de la R   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND; PRIORITY JOURNAL; VACCINE PRODUCTION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; PAROTID GLAND;

EID: 0034084501     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315420     Document Type: Article

References (41)

1. 1. Heilman C, Baltimore D. HIV vaccines: where are we going? Nat Med 1998;4: 532-4.
2. 2. Ho D, Schooley R, Rota T, et al. HTLV-III in the semen and blood of a healthy homosexual man. Science 1984;226:451-3.
3. 3. Wofsy C, Cohen J, Hauer L, et al. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986;1:527-9.
4. 4. Mazanec M, Nedrud J, Kaetzel C, Lamm M. A three-tiered view of the role of IgA in mucosal defense. Immunol Today 1993;14:430-4.
5. 5. Bélec L, Georges A, Steeman G, Martin P. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J Infect Dis 1989;160:385-91.
6. 6. Archibald D, Witt D, Craven D, Vogt M, Hirsch M, Essex M. Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. J Infect Dis 1987;156:240-1.
7. 7. Bélec L, Georges A, Steeman G, Martin P. Antibodies to human immunodeficiency virus in the semen of heterosexual men. J Infect Dis 1989;159: 324-7.
8. 8. Bélec L, Bouquety J, Georges A, Siopathis M, Martin P. Antibodies to human immunodeficiency virus in the breast milk of healthy seropositive women. Pediatrics 1990;85:1022-6.
9. 9. Janoff E, Jackson S, Wahl S, Thomas K, Peterman J, Smith P. Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection. J Infect Dis 1994;170:299-307.
10. 10. Moja P, Jalil A, Quesnel A, et al. Humoral immune response within the lung in HIV-1 infection. Clin Exp Immunol 1997;110:341-8.
11. 11. Cartry O, Moja P, Quesnel A, Pozzetto P, Lucht F, Genin C. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection. Clin Exp Immunol 1997;109: 47-53.
12. 12. Wendler I, Bienzle U, Hunsmann G. Neutralizing antibodies and the course of HIV-induced disease. AIDS Res Hum Retroviruses 1987;3:157-63.
13. 13. Montefiori D, Pantaleo G, Fink L, et al. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus 1 in long-term non-progressors, J Infect Dis 1996;173:60-7.
14. 14. Burnett P, VanCott T, Polonis V, Redfield R, Birx D. Serum IgA-mediated neutralization of HIV type 1. J Immunol 1994;152:4642-8.
15. 15. Kozlowski P, Chen D, Eldridge J, Jackson S. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals. AIDS Res Hum Retroviruses 1994;10:813-22.
16. 16. Kozlowski P, Black K, Shen L, Jackson S. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. J Immunol 1995;154:6163-73.
17. 17. Mazzoli S, Trabattoni D, Caputo SL, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV seropositive individuals. Nat Med 1997;3:1250-7.
18. 18. Bomsel M, Heyman M, Hocini H, et al. Intracellular neutralization of HIV transcylosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 1998;9:277-87.
19. 19. Quesnel A, Pozzetto B, Moja P, et al. Prognostic value of serum immunoglobulin A antibodies to pol gene products during HIV-1 infection. Clin Exp Immunol 1993;91:237-40.
20. 20. McNeely T, Dealy M, Dripps D, Orenstein J, Eisenberg S, Wahl S. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995;96: 456-64.
21. 21. Fraisier C, Ebersold A, Blomberg J, Desgranges C, Primary in vitro immunization with multimeric synthetic peptides of HIV-1 envelope glycoproteins: generation of neutralizing human monoclonal antibodies. J Immunol Methods 1994;176:9-22.
22. 22. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 1997;3:42-7.
23. 23. Lee S, Peden K, Dimitrov DS, et al. Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody. J Virol 1997;71:6037-43.
24. 24. Prohászka Z, Nemes J, Hidvégi T, et al. Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection. AIDS 1997;11:949-58.
25. 25. Poignard P, Klasse P, Sattentau Q. Antibody neutralization of HIV-1. Immunol Today 1996;17:239-46.
26. 26. Bélec L, Tévi-Bénissan C, Lu XS, Prazuck T, Pillot J. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection. AIDS Res Hum Retroviruses 1995;11:719-29.
27. 27. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987;7:265-76.
28. 28. Hocini H, Bélec L, Iscaki S, et al. High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. AIDS Res Hum Retroviruses 1997; 13:1179-85.
29. 29. Laman J, Schellekens M, Abacioglu Y, et al. Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain. J Virol 1992;66:1823-31.
30. 30. Tilley S, Honnen W, Racho M, Chou T-C, Pinter A. Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120. AIDS Res Hum Retroviruses 1992;8:461-7.
31. 31. VanCott T, Kaminski R, Mascola J, et al. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. J Immunol 1998;160:2000-12.
32. 32. Staats H, Nicols W, Palker T. Systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J Immunol 1996;157:462-72.
33. 33. Lamm M. Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 1997;51:311-40.
34. 34. Gaudin M, Parren P, Weir R, Barbas C, Burton D, Koup R. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID-mice against challenge by primary isolates of HIV-1. Nat Med 1997;3: 1389-93.
35. 35. Zolla-Pazner S, Lubeck M, Xu S, et al. Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees. J Virol 1998;72:1052-9.
36. 36. Lehner T, Wang Y, Cranage M, et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med 1996;2:767-75.
37. 37. Bukawa H, Sekigawa K, Hamajima K, et al. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nat Med 1995;1:681-5.
38. 38. Fantini J, Yahi N, Tourres C, Delézay O, Tamalet C. HIV-1 transmission across the vaginal epithelium. AIDS 1997;11:1663-4.
39. 39. Zambruno G, Giannetti A, Bertazzoni U, Girolomoni G. Langerhans cells and HIV infection. Immunol Today 1995;16:520-4.
40. 40. Kraehenbuhl J, Wain-Hobson S. Breaching barriers. Nat Med 1996; 2: 1080-2.
41. 41. Spira A, Marx P, Patterson B, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:215-5.